Kayo Ichihashi

Improvement of psychiatrists’ clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the ‘Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)’ project: A nationwide dissemination, education, and evaluation study

Yoshikazu Takaesu, Koichiro Watanabe, Shusuke Numata et al. · Psychiatry and Clinical Neurosciences · 2019 · 51 citations · Full text

Medicine, Psychiatry, Mental Health Education +11

Prescription patterns in patients with schizophrenia in Japan: First‐quality indicator data from the survey of “Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)” project

Kayo Ichihashi, Hikaru Hori, Naomi Hasegawa et al. · Neuropsychopharmacology Reports · 2020 · 48 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +15

Anti-stigma training and positive changes in mental illness stigma outcomes in medical students in ten countries: a mediation analysis on pathways via empathy development and anxiety reduction

Laura Potts, Ioannis Bakolis, Tanya Deb et al. · Social Psychiatry and Psychiatric Epidemiology · 2022 · 44 citations · Full text

Social Sciences, Medical Education, Psychiatry +17

Characteristics of discharge prescriptions for patients with schizophrenia or major depressive disorder: Real-world evidence from the Effectiveness of Guidelines for Dissemination and Education (EGUIDE) psychiatric treatment project

Naoki Hashimoto, Norio Yasui‐Furukori, Naomi Hasegawa et al. · Asian Journal of Psychiatry · 2021 · 41 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17

Hypnotic medication use among inpatients with schizophrenia and major depressive disorder: results of a nationwide study

Ryuji Furihata, Rei Otsuki, Naomi Hasegawa et al. · Sleep Medicine · 2021 · 29 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +11